  Background: The US Food and Drug Administration (FDA) regulates medical
devices (MD), which are predicated on a concoction of economic and policy
forces (e.g., supply/demand, crises, patents). Assuming that the number of FDA
MD (Premarketing Notifications (PMN), Approvals (PMAs), and their sum)
Applications behaves similarly to those of other econometrics, this work
explores the hypothesis of the existence (and, if so, the length scale(s)) of
economic cycles (periodicities). Methods: Beyond summary statistics, the
monthly (May, 1976 to December, 2020) number of observed FDA MD Applications
are investigated via an assortment of time series techniques (including:
Discrete Wavelet Transform, Running Moving Average Filter (RMAF), Complete
Ensemble Empirical Mode with Adaptive Noise decomposition (CEEMDAN), and
Seasonal Trend Loess (STL) decomposition) to exhaustively search and
characterize such periodicities. Results: The data were found to be non-normal,
non-stationary (fractional order of integration < 1), non-linear, and strongly
persistent (Hurst > 0.5). Importantly, periodicities exist and follow seasonal,
1 year short-term, 5-6 year (Juglar), and a single 24-year medium-term
(Kuznets) period (when considering the total number of MD Applications).
Economic crises (e.g., COVID-19) do not seem to affect the evolution of the
periodicities. Conclusions: This work concludes that (1) PMA and PMN data may
be viewed as a proxy measure of the MD industry; (2) periodicities exists in
the data with time lengths associated with seasonal/1-year, Juglar and Kuznets
affects; (4) these metrics do not seem affected by specific crises (such as
COVID-19) (similarly with other econometrics used in periodicity assessments);
(5) PMNs and PMAs evolve inversely and suggest a structural industrial
transformation; (6) Total MDs are predicted to continue their decline into the
mid-2020s prior to recovery.
